Old Web
English
Sign In
Acemap
>
authorDetail
>
Christy Cappelletti
Christy Cappelletti
AstraZeneca
Medicine
Metered-dose inhaler
Budesonide
Gastroenterology
Physical therapy
5
Papers
19
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Dose-Ranging and Cumulative Dose Studies of Albuterol Sulfate MDI in Co-Suspension Delivery™ Technology (AS MDI; PT007) in Patients with Asthma: the ASPEN and ANTORA Trials.
2021
Clinical Drug Investigation
Christy Cappelletti
Andrea Maes
K. Rossman
Michael Gillen
Craig LaForce
Edward Kerwin
Colin Reisner
Show All
Source
Cite
Save
Citations (1)
Albuterol/budesonide for the treatment of exercise-induced bronchoconstriction in patients with asthma: the TYREE study
2021
Annals of Allergy Asthma & Immunology
Craig LaForce
Bradley E. Chipps
Frank C. Albers
Laurence Reilly
Eva Johnsson
Helen Andrews
Christy Cappelletti
Andrea Maes
Alberto Papi
Show All
Source
Cite
Save
Citations (0)
Efficacy and safety of budesonide/formoterol fumarate dihydrate metered dose inhaler (BFF MDI) using co-suspension delivery technology compared to monocomponents and an active comparator in COPD
2018
European Respiratory Journal
Gary T. Ferguson
Alberto Papi
Antonio Anzueto
Edward Kerwin
Christy Cappelletti
Elizabeth A. Duncan
Jack Nyberg
Paul M. Dorinsky
Show All
Source
Cite
Save
Citations (0)
Budesonide/formoterol MDI with co-suspension delivery technology in COPD: the TELOS study
2018
European Respiratory Journal
Gary T. Ferguson
Alberto Papi
Antonio Anzueto
Edward Kerwin
Christy Cappelletti
Elizabeth A. Duncan
Jack Nyberg
Paul M. Dorinsky
Show All
Source
Cite
Save
Citations (9)
Reaching beyond disparity: safely improving asthma control in the at-risk African-American population.
2013
Journal of The National Medical Association
Randall W. Brown
Christy Cappelletti
Show All
Source
Cite
Save
Citations (9)
1